2^nd World Congress on Health Economics Policy & Outcomes Research June 29-30, 2017 Madrid, Spain

Sarah Neville is the Director, Pricing at the Independent Hospital Pricing Authority (IHPA), and is responsible for delivering the National Efficient Price annually. Sarah’s background is in mathematics and statistics, holding a Ph.D. in statistics from the University of Wollongong. She was invited to present doctoral research at the University of Oxford in 2012. Sarah recently spent six weeks in remote Australia working with Miwatj Health Aboriginal Corporation developing better ways to communicate key health statistics to Indigenous Australians.

Dr. Ailawadhi has expertise in the field of plasma cell disorders, specifically multiple myeloma and focuses on clinical drug development as well as a special interest in secondary data analysis looking at outcome disparities and healthcare economics. He has accumulated vast experience in the area of disparities in healthcare utilization and outcomes by patient race and ethnicity and how the management, access and effects of therapeutic interventions may be different for various patient subgroups. Several of his research projects focusing on healthcare economics, cost-effectiveness and outcome disparities have been recognized in the form of presentations at national and international meetings as well as peer-reviewed publications.

Samath D. Dharmaratne is an Associate Professor and a Consultant Community Physician attached to the Department of Community Medicine, Faculty of Medicine, University of Peradeniya, Sri Lanka and has been in the permanent academic cadre for the past 22 years. Samath was a former Head of the Department, a former Public Health specialist in the World Bank, and a former postgraduate fellow in the University of Washington. He is a Senior Fellow of the Postgraduate Institute of Medicine, University of Colombo. He is a Board Director of the Consortium of Universities for Global Health and the Course Coordinator of the Diploma in Exercise and Sport Sciences, Faculty of Medicine.

Fernando Antonanzas (PhD Economics Univ. Autonoma of Madrid 1983, Master of Arts, The University of Chicago 1985) is professor of Applied Economics at the University of La Rioja (Spain). He has been professor in other universities such as Alicante, Madrid and Zaragose. He has participated in sever post-graduate programmes of different universities related to Health Economics. He was president of the Spanish Health Economics Association for two years during the nineties. He has participated in the organization of several international and national congresses of health economics and has been a member of their scientific and management committees. During the last twenty years he has also participated in some regional and national advisory boards on health policy. He has an extended network of other researchers in the field of health economics in EU countries as well as in the Americas.

Richeal M. Burns is a health economist specializing in economic evaluation alongside clinical trials and burden of illness studies. Richeal has been involved in a range of disease areas including Prostate Cancer, Blood Disorders, Inflammatory Bowel Disease, Childhood Behaviors and Cardiovascular Disease. Her interests include examining methodological concerns in measuring quality of life and the application of quality of life measurement in economic evaluation

Senior Lecturer / Professor in the International Master Program - Lecture: Communication Management in the Public Sector-University of Economics, Prague, Czech Republic, Lecturer at the Management Center Innsbruck (MCI), Austria, for the study program of “Nonprofit, Social & Health Care Management” in the Bachelor and “International Health and Social Management in the Master” Lecture in “Project Work” at the MCI study program of “Social Work, Social Policy and Management” in the Master Module “Current Research and Methods”

Arun Kumar Aggarwal is MD in Community Medicine and postgraduate in Health & Hospital Administration. He is Professor in School of Public Health of premier tertiary care institute (PGIMER) at Chandigarh, North India. He has done WHO fellowship in Health Financing & Economics from Bangkok and World Bank online course on Basics of Health Economics.

Sushil Ranjan Howlader was Professor and Director of the Department of Economics of University of Dhaka from 1995 1998 and thereafter became professor of the institute of health Economics of University of Dhaka, Dhaka. He was the founder Director of the Institute of Health Economics of University of Dhaka and worked as Director from 1998 to 2005 and again from 2007 to 2010 (July). He is also the former Director of the Bureau of Economic Research, University of Dhaka.He has carried out his doctoral study as a Winrock scholar on Development Economics at Jawaharlal Nehru University, New Delhi, in 1993.

Rafia Rahman works as Assistant Professor, Lecturer at Institute of Health Economics, University of Dhaka. She works with national and international NGOs for around nine years then an academician. Her wishes to increase, ensure health care services by registered trained provider in the countries. Rafia also has work experiences like, Training on “Norplant”, conducted by Mohammadpur Fertility Services & Training Center, Training on “No-Scalpel Vasectomy (NSV)” conducted by AITEM, Dhaka, Completed “Continuous Technology Update (CTU)” workshop organized by NSDP, Attended a training on “Integrated Management on Childhood Illness (IMCI)” at Dhaka Shishu Hospital, Attended a training on “Follow-up after IMCI Training”– at Ad din Hospital organized by NSDP, Completed “RTI/STI Management training” organized by NSDP, conducted by Radda MCH, “Quality Monitoring & Supervision of TB Program” workshop organized by URC, Supervision and performance evaluation of medical staff, Maintain liaison between the hospital and providing training to relevant medical and Skilled Birth Attendants (SBA), Developed an on-going training program for nursing and clinical staff, Provide Active Management of Third Stage of Labor (AMTSL) in four (04) districts of Bangladesh. She Attended 9th south East Asia Regional Scientific Meeting,” Epidemiology: A key to Achieve the Millennium development Goals” Workshop.

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA.

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

Katarzyna is a Market Access Director for Region East at Lundbeck. In the past, she worked for AstraZeneca, Bristol Myers Squibb as well as BiogenIdec leading Market Access teams in CEE Region. In total, she has been working for pharmaceutical industry for more than ten years now. The last six years she devoted mainly to Market Access for CEE Region. Her office is located in Finland. In the past she was based in Sweden and Switzerland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa has been invited to review manuscripts for Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union\'s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes.

Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees.Asche’s research is funded by a variety of state/federal agencies and health system providers.